These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1045 related articles for article (PubMed ID: 15541720)

  • 1. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C; Chen N; Sawadogo M
    Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells.
    Chang JT; Yang HT; Wang TC; Cheng AJ
    Mol Carcinog; 2005 Nov; 44(3):183-92. PubMed ID: 16010690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of USF transcriptional activity in breast cancer cell lines.
    Ismail PM; Lu T; Sawadogo M
    Oncogene; 1999 Sep; 18(40):5582-91. PubMed ID: 10523835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a cancer-specific switch at the CDK4 promoter with loss of control by both USF and c-Myc.
    Pawar SA; Szentirmay MN; Hermeking H; Sawadogo M
    Oncogene; 2004 Aug; 23(36):6125-35. PubMed ID: 15208653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
    Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
    Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
    Marcotte R; Chen JM; Huard S; Wang E
    J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions.
    Koskinen PJ; Ayer DE; Eisenman RN
    Cell Growth Differ; 1995 Jun; 6(6):623-9. PubMed ID: 7669717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproliferative properties of the USF family of helix-loop-helix transcription factors.
    Luo X; Sawadogo M
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1308-13. PubMed ID: 8577760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of overexpressed sp1 protein in human fibrosarcoma cell lines inhibits tumor formation.
    Lou Z; O'Reilly S; Liang H; Maher VM; Sleight SD; McCormick JJ
    Cancer Res; 2005 Feb; 65(3):1007-17. PubMed ID: 15705902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
    Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
    Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins.
    Cerni C; Bousset K; Seelos C; Burkhardt H; Henriksson M; Lüscher B
    Oncogene; 1995 Aug; 11(3):587-96. PubMed ID: 7630643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of transcriptional repression by max homodimers.
    Yin X; Grove L; Prochownik EV
    Oncogene; 1998 May; 16(20):2629-37. PubMed ID: 9632139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
    Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
    J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
    Gupta K; Anand G; Yin X; Grove L; Prochownik EV
    Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell growth suppression by thanatos-associated protein 11(THAP11) is mediated by transcriptional downregulation of c-Myc.
    Zhu CY; Li CY; Li Y; Zhan YQ; Li YH; Xu CW; Xu WX; Sun HB; Yang XM
    Cell Death Differ; 2009 Mar; 16(3):395-405. PubMed ID: 19008924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
    Foos G; Hauser CA
    Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USF/c-Myc enhances, while Yin-Yang 1 suppresses, the promoter activity of CXCR4, a coreceptor for HIV-1 entry.
    Moriuchi M; Moriuchi H; Margolis DM; Fauci AS
    J Immunol; 1999 May; 162(10):5986-92. PubMed ID: 10229837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth-dependent and PKC-mediated translational regulation of the upstream stimulating factor-2 (USF2) mRNA in hematopoietic cells.
    Zhang ZC; Nechushtan H; Jacob-Hirsch J; Avni D; Meyuhas O; Razin E
    Oncogene; 1998 Feb; 16(6):763-9. PubMed ID: 9488040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1.
    Rao G; Alland L; Guida P; Schreiber-Agus N; Chen K; Chin L; Rochelle JM; Seldin MF; Skoultchi AI; DePinho RA
    Oncogene; 1996 Mar; 12(5):1165-72. PubMed ID: 8649810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low molecular weight inhibitors of Myc-Max interaction and function.
    Yin X; Giap C; Lazo JS; Prochownik EV
    Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.